Chronic Incretin-based therapy in Cystic Fibrosis (Aim 2)

AddtoAny
Share:

WATCH THIS PAGE

Subscribe to be notified of changes or updates to this page.

2 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

The purpose of this research study is to examine and understand the various mechanisms that contribute to Cystic Fibrosis Related Diabetes and gain a better understanding of potential means to treat Cystic Fibrosis Related Diabetes. Participation will include 6-7 visits over 6 months.

Eligibility & Criteria

IRB #:
13-010324
Official Title:
A Randomized, Double Blind, Placebo Controlled Study of the Effectiveness of Chronic Incretin-based therapy on Insulin Secretion in Cystic Fibrosis
Study Phase:
Phase II
Eligible Age Range:
18 - 99 Years
Gender:
All
Study Categories:
Leader
Andrea Kelly

Andrea Kelly, MD, MSCE